One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset.

Hugo D G van WilligenElke WynbergAnouk VerveenMaartje DijkstraBas J VerkaikOrlane J A FigaroaMarianne C de JongAnnelou L I P van der VeenAgata MakowskaNelleke KoedootPythia T NieuwkerkAnders BoydMaria PrinsMenno D de JongGodelieve J de BreeJoost G van den Aardwegnull null

Published in: PloS one (2023)

The prevalence of impaired pulmonary function after twelve months of follow-up, was still significant among those with initially moderate or severe/critical COVID-19. Pulmonary function increased over time in most of the severity groups. These data imply that guidelines regarding revalidation after COVID-19 should target individuals with moderate and severe/critical disease severities.

Keyphrases

sars cov
coronavirus disease
high intensity
early onset
respiratory syndrome coronavirus
electronic health record
big data
clinical practice
drug induced
machine learning